Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Radiation necrosis (RN) remains a challenging complication of upfront radiation therapy for both brain metastases and primary tumors. Despite development of an array of advanced imaging modalities to differentiate RN and true tumor progression, tissue diagnosis remains the gold standard. Synergizing artificial intelligence to assist with imaging and intraoperative pathologic diagnosis may represen...
BACKGROUND: C-X-C motif chemokine receptor 4 (CXCR4)-directed radiopharmaceutical therapy (RPT) represents a promising option for hematologic malignancies. Nevertheless, responses in relapsed and refractory (r/r) multiple myeloma (MM) are heterogenous, emphasizing the need for optimized patient selection before RPT. Current approaches mostly rely on qualitative assessments, confirming relevant CXC...
Monoclonal gammopathies span a continuum from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) to overt...
PURPOSE: Differentiating conjunctival intraepithelial neoplasia (CIN) from pterygium and pseudopterygium remains clinically challenging, especially in...
Computed tomography (CT) is essential to modern clinical practice but contributes substantially to population radiation exposure, particularly in onco...
BACKGROUND: Uncertainty around a patient's prognosis at the end of life remains a major barrier to timely palliative-care involvement and alignment of...
Understanding the decision-making process of black-box neural networks is crucial for safe use of AI in high-stakes medical tasks such as histopatholo...
Cytopathology, often abbreviated as cytology, has a central role in the early detection of cancer, such as cervical, lung and bladder cancers, owing t...
OBJECTIVES: To construct a multimodal model integrating computed tomography (CT) imaging, radiotherapy dose, and clinical features to address the clin...
PURPOSE: Immunohistochemistry (IHC) is a crucial step in the diagnostic and therapeutic management of colorectal carcinoma (CRC). This study aimed to ...
BACKGROUND: Recurrent glioblastoma multiforme (rGBM) arises after conventional treatment strategies for primary GBM (pGBM) fail, leading to a more agg...
Early prediction of malignant pleural effusion (MPE) recurrence within 3 months is essential for optimizing management in lung cancer patients. This s...
Cisplatin resistance limits the effectiveness of platinum-based chemotherapy for lung adenocarcinoma, yet practical systemic diagnostics for cisplatin...
BACKGROUND AND OBJECTIVE: Most prostate cancer prevention strategies suggest lifestyle modifications, which lack personalization. Gut microbiome is in...
Minimal/measurable residual disease detection is routinely performed as part of post-diagnostic treatment plans for many types of cancer, for which mu...
Prostate cancer is among the most diagnosed malignancies in men worldwide and a leading cause of cancer-related mortality. Early and accurate diagnosi...
BACKGROUND: Smartphone applications that use artificial intelligence (AI) for skin cancer diagnosis may assist in early detection. However, prospectiv...
Biochemical recurrence (BCR) is a critical factor affecting the prognosis of prostate cancer (PCa) patients, while T cell exhaustion and metastatic pr...
BACKGROUND: Accurate non-invasive diagnosis of early-stage ovarian cancer remains challenging because of the limited number of biomarkers. Although ar...